Jennifer Robblee MD

Headache neurologist @BarrowNeuro. Chronic migraine too. (views are my own) #NotJustAHeadache she/her

[Brad Racette, MD @BradRacette]

A population-based, case-control study from my lab associated the gout medication allopurinol with a lower risk of #Alzheimers, #Parkinsons, & #ALS. Our findings were published yesterday in @PLOSOne. Learn more: https://t.co/vmIMHKewzu. #ALSMonth

[BarrowNeurological @BarrowNeuro]

A population-based, case-control study co-authored by Barrow #Neurology Chairman & Senior VP Dr. @BradRacette associated a common gout medication with a reduced risk of #Alzheimers, #Parkinsons, & #ALS. Press release: https://t.co/6wv1CsEL2U

#ALSMonth #ALSAwarenessMonth

[American Headache Society @ahsheadache]

The AHS and @NINDSnews are soliciting input from all interested stakeholders, including researchers, health care providers, individuals with #headache disorders, patient advocates and health #advocacy organizations, scientific or professional organizations, federal agencies, and interested members of the public. Learn more: https://t.co/tFiLGbTR6B

To assure consideration, responses must be received by July 31, 2023 and should be submitted electronically using the web-based form here: https://t.co/UValtfYHgZ #NeuroTwitter

[Jennifer Robblee MD @JenniferRobblee]

@DrHopeMO @AANmember @MaryPostCEO @CarlayneJackson @tcascino1 @nsanar @JimStevensMD @FlippenII @chadehum @headacheMD @rashmihalker @melissarayhill @mendizabal_md @RachelSalasMD @neurobickel @Marsha74Smith @JeffreyMcclean @OligoclonalBand See you there!!!!

[Jennifer Robblee MD @JenniferRobblee]

Look at all of us!! What an inspiring group of powerful women!! ❤️

[Women Neurologists Group @WNGtweets]

We had a wonderful time at the #AANAM in Boston! If you are a woman neurologist and are looking for support, connection and free CME all year round, join our group on Facebook! #neurology https://t.co/yhpHk2sco0

[Jennifer Robblee MD @JenniferRobblee]

@abhobneuro You too!! ❤️

[Jennifer Robblee MD @JenniferRobblee]

Finish line is here. What a great week at #AANAM 2023 in Boston! Thanks for all the learning, networking and inspiration. And my hat!

[Brad Racette, MD @BradRacette]

The Barrow Neuromuscular Disorders team, led by Shafeeq Ladha, played a key role in research trials that led to the approval of #tofersen. The new drug targets a genetic form of #ALS and is a great example of personalized medicine for ALS.

https://t.co/KvcoJGLKpz

[Jennifer Robblee MD @JenniferRobblee]

@CSWhiteMD It looks like a path slide, not MRI. Just incredible! Science is so cool!!

[Jennifer Robblee MD @JenniferRobblee]

@NinaRiggins @AANmember @EhrlichNP @WNGtweets Love it!!

[Jennifer Robblee MD @JenniferRobblee]

Power team this morning!! ❤️ #AANAM

[Jose Posas, MD, FAAN @jposas]

And that’s a wrap! Thank you @AANmember @JenniferRobblee @headacheMD for allowing me to present this morning about concussions in the ER! More amazing #womeninneurology in the series of pictures. #thisiswhataneurologistlookslike

[Jennifer Robblee MD @JenniferRobblee]

@BarrowNeuro

[Jennifer Robblee MD @JenniferRobblee]

Calling all early birds! Come learn about headache in the emergency room today at 7am with myself, @headacheMD & @jposas on the last day of #AANAM

[Jennifer Robblee MD @JenniferRobblee]

@BertVargas @AANmember You mean the session that won #AANAM ?

[Jennifer Robblee MD @JenniferRobblee]

@AANmember I am now de-stressed.

[Jennifer Robblee MD @JenniferRobblee]

@AANmember Yes.

[Jennifer Robblee MD @JenniferRobblee]

DHE via IV was viewed as a favorable treatment for status migrainosus, though it was underutilized and often only as a last resort due to accessibility issues.

INP104 allows patients to administer DHE at home with IV-like efficacy.

Abstract: https://t.co/Up61mLibew

[Jennifer Robblee MD @JenniferRobblee]

Check out my poster at #AANAM today!

Status migrainosus is a debilitating #migraine complication with intense symptoms lasting over 72h. Our survey entailed phone interviews with 33 headache specialists from across the U.S.

[Jennifer Robblee MD @JenniferRobblee]

Check out my poster at #AANAM today!

Status migrainosus is a debilitating #migraine complication with intense symptoms lasting over 72h. Our survey entailed phone interviews with 33 headache specialists from across the U.S.

[Jennifer Robblee MD @JenniferRobblee]

Come learn how headache neurologists currently approach status migrainosus and participate in the survey yourself! Happening soon in neighborhood 12! Come visit me to chat!
#AANAM @BarrowNeuro

[Jennifer Robblee MD @JenniferRobblee]

Come learn how headache neurologists currently approach status migrainosus and participate in the survey yourself! Happening soon in neighborhood 12! Come visit me to chat!
#AANAM @BarrowNeuro